Current Status of Cardiac Anesthesiology and Intensive Care

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Intensive Care".

Deadline for manuscript submissions: closed (25 October 2021) | Viewed by 23525

Special Issue Editor


E-Mail Website
Guest Editor
CardioVascular Unit, Intensive Care Division, Geneva University Hospitals, 1205 Geneva, Switzerland
Interests: physiology; cardiology; anesthesiology; intensive care; hemodynamic; echocardiography; ECMO
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The modus operandi for anesthesiologists and intensivists is to maintain adequate organ perfusion during high risk procedures and for patients suffering from severe diseases. In this regard, cardiac surgical patients face a risk of perioperative organ injury, even when a surgical procedure is performed for the appropriate indication and in a technically perfect manner. This risk is related to the complexity of disease in certain patients as well as their procedures, which make stroke, myocardial infarction, respiratory failure, hemorrhagic shock, acute kidney injury, and acute gut injury, among the most common complications. The editorial office of Journal of Clinical Medicine believe that research providing mechanistic insight into the complications of cardiovascular surgery represents one of the most important opportunities to improve knowledge of the hemodynamic management of these patients regarding both the operation room and the intensive care unit.

To facilitate discussion on this topic, the Journal of Clinical Medicine calls for papers for a thematic issue on “Current Status of Cardiac Anesthesiology and Intensive Care” to be guest edited by Prof Karim Bendjelid. We are seeking submissions of original research that discusses the physiology and pathophysiology of cardiovascular surgery; discusses fundamental and clinical research in areas related to this topic; or provides select examples for novel treatments, paradigms, and concepts that have emerged over the past decade.

Authors should review the Journal’s current Instructions for Authors at https://www.mdpi.com/journal/jcm/instructions.

Publication of the “Current Status of Cardiac Anesthesiology and Intensive Care” Thematic Issue is planned for early 2021.

Interested authors can contact Prof. Dr. Karim Bendjelid, karim.bendjelid@hcuge.ch, for additional information or to discuss specific topic proposals for the “Current Status of Cardiac Anesthesiology and Intensive Care” Thematic Issue.

Prof. Dr. Karim Bendjelid
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cardiovascular surgery
  • Anesthesiology
  • Intensive care
  • Novel treatments
  • Cardiology

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

3 pages, 2047 KiB  
Editorial
Intra-Aortic Balloon Pump and Ischemic Cardiogenic Shock May Still Be a Valuable Association
by Florian Rey, Raphaël Giraud and Karim Bendjelid
J. Clin. Med. 2021, 10(4), 778; https://doi.org/10.3390/jcm10040778 - 16 Feb 2021
Cited by 2 | Viewed by 3478
Abstract
The IABP gives rise to greater myocardial perfusion by increasing the coronary pressure gradient from the aorta to the coronary circulation at a time when the aortic valve is closed [...] Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

Research

Jump to: Editorial, Review

10 pages, 2032 KiB  
Article
To Balloon or Not to Balloon? The Effects of an Intra-Aortic Balloon-Pump on Coronary Artery Flow during Extracorporeal Circulation Simulating Normal and Low Cardiac Output Syndromes
by Philippe Reymond, Karim Bendjelid, Raphaël Giraud, Gérald Richard, Nicolas Murith, Mustafa Cikirikcioglu and Christoph Huber
J. Clin. Med. 2021, 10(22), 5333; https://doi.org/10.3390/jcm10225333 - 16 Nov 2021
Cited by 2 | Viewed by 2403
Abstract
ECMO is the most frequently used mechanical support for patients suffering from low cardiac output syndrome. Combining IABP with ECMO is believed to increase coronary artery blood flow, decrease high afterload, and restore systemic pulsatile flow conditions. This study evaluates that combined effect [...] Read more.
ECMO is the most frequently used mechanical support for patients suffering from low cardiac output syndrome. Combining IABP with ECMO is believed to increase coronary artery blood flow, decrease high afterload, and restore systemic pulsatile flow conditions. This study evaluates that combined effect on coronary artery flow during various load conditions using an in vitro circuit. In doing so, different clinical scenarios were simulated, such as normal cardiac output and moderate-to-severe heart failure. In the heart failure scenarios, we used peripheral ECMO support to compensate for the lowered cardiac output value and reach a default normal value. The increase in coronary blood flow using the combined IABP-ECMO setup was more noticeable in low heart rate conditions. At baseline, intermediate and severe LV failure levels, adding IABP increased coronary mean flow by 16%, 7.5%, and 3.4% (HR 60 bpm) and by 6%, 4.5%, and 2.5% (HR 100 bpm) respectively. Based on our in vitro study results, combining ECMO and IABP in a heart failure setup further improves coronary blood flow. This effect was more pronounced at a lower heart rate and decreased with heart failure, which might positively impact recovery from cardiac failure. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Graphical abstract

15 pages, 1345 KiB  
Article
Application of an Exploratory Knowledge-Discovery Pipeline Based on Machine Learning to Multi-Scale OMICS Data to Characterise Myocardial Injury in a Cohort of Patients with Septic Shock: An Observational Study
by Bernardo Bollen Pinto, Vicent Ribas Ripoll, Paula Subías-Beltrán, Antoine Herpain, Cristina Barlassina, Eliandre Oliveira, Roberta Pastorelli, Daniele Braga, Matteo Barcella, Laia Subirats, Julia Bauzá-Martinez, Antonia Odena, Manuela Ferrario, Giuseppe Baselli, Federico Aletti, Karim Bendjelid and on behalf of the Shockomics Consortium
J. Clin. Med. 2021, 10(19), 4354; https://doi.org/10.3390/jcm10194354 - 24 Sep 2021
Cited by 2 | Viewed by 2141
Abstract
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysfunction in sepsis. In this study, we used a machine learning (ML) pipeline to explore transcriptomic, proteomic, and metabolomic data from patients with septic shock, and prospectively collected measurements [...] Read more.
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysfunction in sepsis. In this study, we used a machine learning (ML) pipeline to explore transcriptomic, proteomic, and metabolomic data from patients with septic shock, and prospectively collected measurements of high-sensitive cardiac troponin and echocardiography. The purposes of the study were to suggest an exploratory methodology to identify and characterise the multiOMICs profile of (i) myocardial injury in patients with septic shock, and of (ii) cardiac dysfunction in patients with myocardial injury. The study included 27 adult patients admitted for septic shock. Peripheral blood samples for OMICS analysis and measurements of high-sensitive cardiac troponin T (hscTnT) were collected at two time points during the ICU stay. A ML-based study was designed and implemented to untangle the relations among the OMICS domains and the aforesaid biomarkers. The resulting ML pipeline consisted of two main experimental phases: recursive feature selection (FS) assessing the stability of biomarkers, and classification to characterise the multiOMICS profile of the target biomarkers. The application of a ML pipeline to circulate OMICS data in patients with septic shock has the potential to predict the risk of myocardial injury and the risk of cardiac dysfunction. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

10 pages, 573 KiB  
Article
Airway Care Interventions for Invasively Ventilated Critically Ill Adults—A Dutch National Survey
by Willemke Stilma, Sophia M. van der Hoeven, Wilma J. M. Scholte op Reimer, Marcus J. Schultz, Louise Rose and Frederique Paulus
J. Clin. Med. 2021, 10(15), 3381; https://doi.org/10.3390/jcm10153381 - 30 Jul 2021
Cited by 8 | Viewed by 2602
Abstract
Airway care interventions may prevent accumulation of airway secretions and promote their evacuation, but evidence is scarce. Interventions include heated humidification, nebulization of mucolytics and/or bronchodilators, manual hyperinflation and use of mechanical insufflation-exsufflation (MI-E). Our aim is to identify current airway care practices [...] Read more.
Airway care interventions may prevent accumulation of airway secretions and promote their evacuation, but evidence is scarce. Interventions include heated humidification, nebulization of mucolytics and/or bronchodilators, manual hyperinflation and use of mechanical insufflation-exsufflation (MI-E). Our aim is to identify current airway care practices for invasively ventilated patients in intensive care units (ICU) in the Netherlands. A self–administered web-based survey was sent to a single pre–appointed representative of all ICUs in the Netherlands. Response rate was 85% (72 ICUs). We found substantial heterogeneity in the intensity and combinations of airway care interventions used. Most (81%) ICUs reported using heated humidification as a routine prophylactic intervention. All (100%) responding ICUs used nebulized mucolytics and/or bronchodilators; however, only 43% ICUs reported nebulization as a routine prophylactic intervention. Most (81%) ICUs used manual hyperinflation, although only initiated with a clinical indication like difficult oxygenation. Few (22%) ICUs used MI-E for invasively ventilated patients. Use was always based on the indication of insufficient cough strength or as a continuation of home use. In the Netherlands, use of routine prophylactic airway care interventions is common despite evidence of no benefit. There is an urgent need for evidence of the benefit of these interventions to inform evidence-based guidelines. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

10 pages, 586 KiB  
Article
Relationship between 30 Days Mortality and Incidence of Intraoperative Cardiac Arrest According to the Timing of ECMO
by Taehwa Kim, Seungeun Lee and Sungkwang Lee
J. Clin. Med. 2021, 10(9), 1977; https://doi.org/10.3390/jcm10091977 - 05 May 2021
Viewed by 1488
Abstract
Background: Recently, the use of extracorporeal membrane oxygenation (ECMO) in noncardiac surgery, such as thoracic surgery, has increased. However, there have been no studies on the mortality and incidence of intraoperative cardiac arrest with or without ECMO during thoracic surgery. Methods: Between January [...] Read more.
Background: Recently, the use of extracorporeal membrane oxygenation (ECMO) in noncardiac surgery, such as thoracic surgery, has increased. However, there have been no studies on the mortality and incidence of intraoperative cardiac arrest with or without ECMO during thoracic surgery. Methods: Between January 2011 and October 2018, 63 patients received ECMO support during thoracic surgery. All patients who applied ECMO from starting at any time before surgery to the day of surgery were included. Patients were divided into the emergency ECMO group and the non-emergency ECMO group according to the timing of ECMO. We compared the factors related to 30 day mortality using Cox regression analysis. Results: The emergency ECMO and non-emergency ECMO groups comprised 27 and 36 patients, respectively. On the operation day, cardiopulmonary resuscitation (CPR) was a very important result, and only occurred in the emergency ECMO group (n = 20, 74.1% vs. 0%, p < 0.001). The most common cause of ECMO indication was the CPR in the emergency ECMO group and respiratory failure in the non-emergency ECMO group. There were significant differences in 30 day mortality between the emergency ECMO group and the non-emergency ECMO group (n = 12, 44.4% vs. n = 3, 8.3%, p = 0.001). The Kaplan–Meier analysis curve for 30 day mortality showed that the emergency ECMO group had a significantly higher rate of 30 day mortality than the non-emergency ECMO group (X2 = 14.7, p < 0.001). Conclusions: A lower incidence of intraoperative cardiac arrest occurred in the non-emergency ECMO group than in the emergency ECMO group. Moreover, 30 day mortality was associated with emergency ECMO. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

9 pages, 1456 KiB  
Article
Kinetic GFR Outperforms CKD-EPI for Slow Graft Function Prediction in the Immediate Postoperative Period Following Kidney Transplantation
by Jonathan Dash, Thomas Verissimo, Anna Faivre, Lena Berchtold, Thierry Berney, Jérôme Pugin, Sophie de Seigneux and David Legouis
J. Clin. Med. 2020, 9(12), 4003; https://doi.org/10.3390/jcm9124003 - 10 Dec 2020
Cited by 4 | Viewed by 2129
Abstract
Background: Rapid identification of patients at high risk for slow graft function (SGF) is of major importance in the immediate period following renal graft transplantation, both for early therapeutic decisions and long-term prognosis. Due to the high variability of serum creatinine levels after [...] Read more.
Background: Rapid identification of patients at high risk for slow graft function (SGF) is of major importance in the immediate period following renal graft transplantation, both for early therapeutic decisions and long-term prognosis. Due to the high variability of serum creatinine levels after surgery, glomerular filtration rate (GFR) estimation is challenging. In this situation, kinetic estimated GFR (KeGFR) equations are interesting tools but have never been assessed for the identification of SGF patients. Methods: We conducted a single-center retrospective cohort study, including all consecutive kidney allograft recipients in the University Hospitals of Geneva from 2008 to 2016. GFR was estimated using both CKD-EPI and KeGFR formulae. Their accuracies for SGF prediction were compared. Patients were followed up for one year after transplantation. Results: A total of 326 kidney recipients were analyzed. SGF occurred in 76 (23%) patients. KeGFR estimation stabilized from the day following kidney transplantation, more rapidly than CKD-EPI. Discrimination ability for SGF prediction was better for KeGFR than CKD-EPI (AUC 0.82 and 0.66, p < 0.001, respectively). Conclusion: KeGFR computed from the first day after renal transplantation was able to predict SGF with good discrimination, outperforming CKD-EPI estimation. SGF patients had lower renal graft function overall at the one-year follow up. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

Review

Jump to: Editorial, Research

30 pages, 1657 KiB  
Review
The Right Ventricle in COVID-19
by Jean Bonnemain, Zied Ltaief and Lucas Liaudet
J. Clin. Med. 2021, 10(12), 2535; https://doi.org/10.3390/jcm10122535 - 08 Jun 2021
Cited by 18 | Viewed by 4141
Abstract
Infection with the novel severe acute respiratory coronavirus-2 (SARS-CoV2) results in COVID-19, a disease primarily affecting the respiratory system to provoke a spectrum of clinical manifestations, the most severe being acute respiratory distress syndrome (ARDS). A significant proportion of COVID-19 patients also develop [...] Read more.
Infection with the novel severe acute respiratory coronavirus-2 (SARS-CoV2) results in COVID-19, a disease primarily affecting the respiratory system to provoke a spectrum of clinical manifestations, the most severe being acute respiratory distress syndrome (ARDS). A significant proportion of COVID-19 patients also develop various cardiac complications, among which dysfunction of the right ventricle (RV) appears particularly common, especially in severe forms of the disease, and which is associated with a dismal prognosis. Echocardiographic studies indeed reveal right ventricular dysfunction in up to 40% of patients, a proportion even greater when the RV is explored with strain imaging echocardiography. The pathophysiological mechanisms of RV dysfunction in COVID-19 include processes increasing the pulmonary vascular hydraulic load and others reducing RV contractility, which precipitate the acute uncoupling of the RV with the pulmonary circulation. Understanding these mechanisms provides the fundamental basis for the adequate therapeutic management of RV dysfunction, which incorporates protective mechanical ventilation, the prevention and treatment of pulmonary vasoconstriction and thrombotic complications, as well as the appropriate management of RV preload and contractility. This comprehensive review provides a detailed update of the evidence of RV dysfunction in COVID-19, its pathophysiological mechanisms, and its therapy. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

22 pages, 1736 KiB  
Review
Challenges in Patient Blood Management for Cardiac Surgery: A Narrative Review
by Valentina Rancati, Emmanuelle Scala, Zied Ltaief, Mohamed Ziyad Gunga, Matthias Kirsch, Lorenzo Rosner and Carlo Marcucci
J. Clin. Med. 2021, 10(11), 2454; https://doi.org/10.3390/jcm10112454 - 01 Jun 2021
Cited by 8 | Viewed by 4037
Abstract
About 15 years ago, Patient Blood Management (PBM) emerged as a new paradigm in perioperative medicine and rapidly found support of all major medical societies and government bodies. Blood products are precious, scarce and expensive and their use is frequently associated with adverse [...] Read more.
About 15 years ago, Patient Blood Management (PBM) emerged as a new paradigm in perioperative medicine and rapidly found support of all major medical societies and government bodies. Blood products are precious, scarce and expensive and their use is frequently associated with adverse short- and long-term outcomes. Recommendations and guidelines on the topic are published in an increasing rate. The concept aims at using an evidence-based approach to rationalize transfusion practices by optimizing the patient’s red blood cell mass in the pre-, intra- and postoperative periods. However, elegant as a concept, the implementation of a PBM program on an institutional level or even in a single surgical discipline like cardiac surgery, can be easier said than done. Many barriers, such as dogmatic ideas, logistics and lack of support from the medical and administrative departments need to be overcome and each center must find solutions to their specific problems. In this paper we present a narrative overview of the challenges and updated recommendations for the implementation of a PBM program in cardiac surgery. Full article
(This article belongs to the Special Issue Current Status of Cardiac Anesthesiology and Intensive Care)
Show Figures

Figure 1

Back to TopTop